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Research
Hundreds of time-series studies worldwide pro-
vide compelling evidence of the health effects
of short-term exposure to air pollution. These
studies also pose problems of interpretation due
to variation in analytic methods and reporting,
and the possibility of publication and analytic
bias. Meta-analyses of published results can
provide information about patterns in the rela-
tive rates of mortality and morbidity and evi-
dence as to the causes of their spatial variation,
but they inherit many of the same limitations
of the individual studies. Coordinated multicity
studies, designed partly to address these issues,
have now been conducted in Europe and
North America (Atkinson et al. 2001; Bell et al.
2004; Burnett and Goldberg 2003; Burnett
et al. 1998, 2000; Gryparis et al. 2004;
Katsouyanni et al. 1997, 2001; Samet et al.
2000a, 2000b, 2000c) and currently provide
the most valid epidemiologic evidence of the
effects of short-term exposure. The results of
these studies appear broadly similar, but their
methods and data characteristics differ, pre-
cluding definitive conclusions about their
quantitative consistency and about the extent
of and reasons for differences in the magnitude
of the effects of short-term exposure among
regions of the world.
APHENA (Air Pollution and Health: A
Combined European and North American
Approach) is a collaborative study among
investigators involved in the European
APHEA (Air Pollution and Health: A
European Approach) study (Atkinson et al.
2001; Gryparis et al. 2004; Katsouyanni et al.
1997, 2001) and the U.S. NMMAPS
(National Morbidity, Mortality and Air
Pollution Study) study (Bell et al. 2004;
Samet et al. 2000a, 2000b, 2000c), as well as
Canadian studies (Burnett and Goldberg
2003; Burnett et al. 1998, 2000). APHENA
addresses the short-term health effects of
particulate matter (PM) ≤ 10 µm in aero-
dynamic diameter (PM10) and ozone on daily
mortality and hospital admissions. The pro-
ject originated at a time when the results of
the multicity analyses, including APHEA and
NMMAPS, were being reported and consid-
ered in the development of ambient air qual-
ity standards for PM (European Commission
1999; World Health Organization 2004,
2006). The main objective of the project was
to assess the coherence of the ﬁndings of the
multicity studies carried out in Europe and
North America, when analyzed with a com-
mon protocol, and to explore reasons for any
observed differences in the size of the air
pollution relative rates.
In this article, we present the APHENA
findings on the association between daily
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BACKGROUND: The APHENA (Air Pollution and Health: A Combined European and North
American Approach) study is a collaborative analysis of multicity time-series data on the effect of
air pollution on population health, bringing together data from the European APHEA (Air
Pollution and Health: A European Approach) and U.S. NMMAPS (National Morbidity, Mortality
and Air Pollution Study) projects, along with Canadian data.
OBJECTIVES: The main objective of APHENA was to assess the coherence of the findings of the
multicity studies carried out in Europe and North America, when analyzed with a common proto-
col, and to explore sources of possible heterogeneity. We present APHENA results on the effects of
particulate matter (PM) ≤ 10 µm in aerodynamic diameter (PM10) on the daily number of deaths
for all ages and for those < 75 and ≥ 75 years of age. We explored the impact of potential environ-
mental and socioeconomic factors that may modify this association.
METHODS: In the ﬁrst stage of a two-stage analysis, we used Poisson regression models, with nat-
ural and penalized splines, to adjust for seasonality, with various degrees of freedom. In the second
stage, we used meta-regression approaches to combine time-series results across cites and to assess
effect modiﬁcation by selected ecologic covariates.
RESULTS: Air pollution risk estimates were relatively robust to different modeling approaches. Risk
estimates from Europe and United States were similar, but those from Canada were substantially
higher. The combined effect of PM10 on all-cause mortality across all ages for cities with daily air
pollution data ranged from 0.2% to 0.6% for a 10-µg/m3 increase in ambient PM10 concentration.
Effect modiﬁcation by other pollutants and climatic variables differed in Europe and the United
States. In both of these regions, a higher proportion of older people and higher unemployment
were associated with increased air pollution risk.
CONCLUSIONS: Estimates of the increased mortality associated with PM air pollution based on the
APHENA study were generally comparable with results of previous reports. Overall, risk estimates
were similar in Europe and in the United States but higher in Canada. However, PM10 effect modi-
ﬁcation patterns were somewhat different in Europe and the United States.
KEY WORDS: air pollution, effect modiﬁcation, heterogeneity, meta-regression, mortality, natural
splines, particulate matter, penalized splines, time-series analysis. Environ Health Perspect
116:1480–1486 (2008). doi:10.1289/ehp.11345 available via http://dx.doi.org/ [Online 26 June 2008]measurements of PM10 and mortality. The
results, spanning two continents with a wide
range of sources of ambient air pollution, are
relevant to one of the key uncertainties in our
current understanding of the health effects of
PM: the identiﬁcation of those characteristics
of PM that are associated with toxicity
(National Research Council 2004). Current
regulatory standards are based on overall indi-
cators of airborne PM mass as concentration
metrics, in the face of uncertainty as to the
specific physical and chemical characteristics
that determine toxicity. The present study
permits exploration of heterogeneity in the
effect of PM10 on mortality across the broad
range of atmospheres included in the
APHENA cities.
Any assessment of heterogeneity needs to
address the potential consequences of using dif-
fering analytic strategies to estimate air pollution
health risks, and the extent to which apparent
heterogeneity across studies reﬂects the conse-
quences of different analytical methods. Based
on past work by the APHENA investigators and
extensive sensitivity analysis, we developed uni-
form approaches for first-stage (within-city)
analyses of the time-series data used in previous
reports. We then used the regression estimates
in second-stage analyses directed at characteriz-
ing heterogeneity of the effect of PM10 across
the APHENA cities and identifying factors
contributing to heterogeneity.
Materials and Methods
Data. APHENA was based on previously
assembled databases in the ﬁrst-stage analysis.
The database included the 90 U.S. cities in
NMMAPS (Samet et al. 2000a, 2000b); the
32 European cities in APHEA, of which 22
had PM10 data (Katsouyanni et al. 2001); and
12 larger Canadian cities used in previous
multicity projects, selected on the basis of
availability of air pollution monitoring data
(Burnett and Goldberg 2003; Burnett et al.
1998, 2000).
The databases included daily counts of all-
cause mortality [excluding deaths from external
causes, according to International Classiﬁcation
of Diseases, 9th Revision (World Health
Organization 1975), codes > 800] for all ages
and by age group (≥ 75 years and < 75 years of
age). We obtained air pollution measurements
from fixed-site monitoring stations in each
city. All Canadian cities and 75 U.S. cities had
PM10 measurements every 3 or 6 days. All
European and 15 U.S. cities had a small num-
ber of (apparently random) days on which air
pollution measurements were missing. The 15
U.S. cities with full time-series data were repre-
sentative of the total of 90 U.S. cities with
regard to both mortality rates and air pollution
levels. We used city-speciﬁc time-series data on
daily temperature (°C, daily mean) to control
for the potential confounding effects of
weather. City characteristics both within and
between the three collaborating centers
(Europe, United States, and Canada) exhibit
substantial variability. We provide more details
on the data in the Supplemental Material
(online at http://www.ehponline.org/members/
2008/11345/suppl.pdf).
We restricted analysis to days with PM10
concentrations < 150 µg/m3, because the rela-
tionship between air pollution and mortality
within this range is effectively linear (Dominici
et al. 2002a; Samoli et al. 2005). This restric-
tion led us to exclude < 2% of the available
days in each city, except for three European
cities (Erfurt, Prague, and Turin), in which
we excluded 3–6% of the total number of
available days.
Methods. When APHENA was initiated,
there was ongoing debate about the use of
time-series methods to describe the relation-
ship between air pollution and health after
Dominici et al. (2002b) and Ramsay et al.
(2003) identified modeling issues related to
nonparametric smoothing. At that time, ques-
tions were raised concerning the choice of
smoothing method, the degree of smoothing,
and parametric versus nonparametric methods.
The U.S. Environmental Protection Agency
(EPA) requested that the Health Effects
Institute (HEI) organize a systematic reanaly-
sis of selected studies to assess the sensitivity
of the original estimates produced with non-
parametric modeling strategies, using prespec-
ified alternative modeling approaches. The
results were published in a special report (HEI
2003), which concluded that no particular
method could be recommended as optimal,
and recommended that analysts should incor-
porate extensive sensitivity analyses to assess
the adequacy of control for time-varying
potential confounders.
Consequently, the APHENA investigators
decided to implement a new protocol for
reanalysis of the daily air pollution data from
the European and North American cities.
First, we fit regression models in each city
separately to control for seasonal effects,
weather, and other potential confounders.
Given simulation results (Peng et al. 2006;
Touloumi et al. 2006), we considered two
methods to control for confounding: natural
splines (NS), for parametric modeling of ﬂexi-
ble families of curves (McCullagh and Nelder
1989), and penalized regression splines (PS),
as implemented by Wood (2000) in R.
Initial methodological exploration indi-
cated that the number of degrees of freedom
(df) for control of seasonality was the most
important parameter in model specification
with respect to the magnitude of regression
coefﬁcient reﬂecting the effect of air pollution
on population health. We carried out exten-
sive sensitivity analyses in which we progres-
sively increased df to control for temporal
variation. In the second analytic stage, we
used meta-regression to obtain center-speciﬁc
(Canada, Europe, United States) and overall
estimates of risk based on the city-speciﬁc risk
estimates, and to investigate potential city-
level effect modiﬁers.
Individual city analysis. We investigated
the PM10–mortality associations for each city
using Poisson regression models allowing for
overdispersion. The city-specific model is of
the form
[1]
where E[Yt
c] is the expected value of the
Poisson distributed variable Yt
c indicating the
daily mortality count on day t at city c with
var(Yt
c) = ϕE[Yt
c], with ϕ representing the
overdispersion parameter; PMt
c is the air pol-
lution concentration on day t in city c; and xit
c
is the value of the xi meteorologic covariate on
day t in city c. The smooth functions s capture
the nonlinear relationship between the time-
varying covariates and calendar time and daily
mortality. We used PS and NS as smooth
functions, with k denoting the number of
basis functions. We used NS as basis functions
for the PS. We also included dummy variables
for day of the week and holiday effects.
The smooth function of time serves as a
proxy for any time-dependent outcome predic-
tors or confounders with long-term trends and
seasonal patterns not explicitly included in the
model. Hence, we removed long-term trends
and seasonal patterns from the data to guard
against confounding by omitted covariates. We
used 3, 8, and 12 df for seasonality control.
Additionally, for complete air pollution time
series (i.e., the series without systematic missing
values), we used the minimization of the sum of
the absolute values of the partial autocorrelation
function (PACF) of the model’s residuals as
another criterion to select the optimal df, when
we applied the PS method. The minimum df
allowed under the PACF was 3 df/year. To
control for weather, we included smooth terms
of temperature on the day of death and the day
before death in the time-series models. We used
these terms for temperature because in prior
analyses we found that same-day temperature
accounts for hot-weather effects, whereas previ-
ous-day temperature accounts for cold-weather
effects. We set the df for both temperature
terms at 3, based on an exploratory sensitivity
analysis done within APHENA that indicated
robust results with respect to different
approaches for weather control. For models
based on minimization of PACF, we intro-
duced autoregressive terms, if necessary, in case
signiﬁcant autocorrelation remained in the ﬁnal
model’s residuals.
We did not control for influenza epi-
demics because previously published results
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association between air pollution and mortal-
ity (Braga and Zanobetti 2000; Touloumi
et al. 2005).
We carried out two sets of analyses,
depending on the availability of measurements
in each city. We based the ﬁrst on cities with
complete time-series data (i.e., full daily data,
with only a few days missing at random),
which encompassed all European and 15 U.S.
cities. For these cities, we used the average of
the same and previous day’s air pollution as a
predictor of increased mortality, as well as
unconstrained distributed lag models span-
ning lags 0, 1, and 2. When ﬁtting distributed
lag models, we used the same distributed lag
terms for temperature as for PM10. The sec-
ond set of analyses included all cities, regard-
less of data availability, and assessed only the
effect of the previous day’s air pollution (lag
1). Because the PACF criterion is based on
controlling the autocorrelation in time-series
data, we did not apply it when we analyzed
the previous day’s air pollution, because this
analysis included cities with systematically
missing time-series data, for which case the
concept of autocorrelation is not straightfor-
ward. For complete time series, we then fit
eight models (two smoothers and four sets of
df for seasonality control) in each city for lags
0 and 1, whereas we applied six models (two
smoothers and three sets of df) in cities with
systematically missing data for lag 1 analysis.
To investigate potential confounding
effects by O3, we applied two-pollutant
models that controlled for 1-hr maximum O3
concentrations.
We also carried out center-specific
(Canada, Europe, and United States) threshold
analyses to investigate the exposure–response
relationship between PM10 and all-cause mor-
tality. We used models with NS for con-
founder control with 8 df per year for
seasonality. We selected a grid of threshold val-
ues, ranging from 0 to 75 µg/m3 in increments
of 5 µg/m3 (i.e., 0, 5, 10, up to 75 µg/m3). For
each threshold value h, we fit a threshold
model to the data for the available cities. In the
threshold model, we included a pollutant term
(x+) in the model of the form (pollutant-h)+,
where x+ = x if x ≥ 0 and x+ = 0 if x < 0, where
h is the threshold value. We then computed
the Akaike information criterion (AIC) value
of the ﬁtted model for all cities in each center
for a given threshold value, and then the aver-
age AIC for that threshold over all cities in the
center. We repeated the analysis for all thresh-
old values. We set a possible threshold at the
value that minimized the mean AIC.
Second-stage analysis. The epidemiologic
objectives of the second-stage analysis were to
assess bias due, for example, to exposure
measurement error; and to assess effect modi-
fication of the air pollution relative rates
across study regions. Potential effect modiﬁers
used in the analysis included variables describ-
ing a) the average air pollution level and mix
in each city (specifically, the mean levels,
standard deviations, and coefﬁcients of varia-
tion for PM10, nitrogen dioxide, O3, and sul-
fur dioxide and the ratio of PM10 to NO2);
b) air pollution level exposure (number of
monitors and density of monitors relative to
population size); c) the health status of the
population (cardiorespiratory deaths as a per-
centage of total mortality, crude mortality
rate, directly standardized mortality rate, age
structure described as percentage of the popu-
lation ≥ 65, ≥ 75, and < 15 years of age); and
d) climatic conditions (mean and variance of
temperature and relative humidity levels, and
mean minimum and maximum daily temper-
ature). There were few comparable socio-
economic status (SES) indicators across the
different countries in Europe at the city level;
indeed, only unemployment rate (percent)
was available for 14 cities. Unemployment
data were available for all U.S. cities.
In the second stage of the analysis, we
assumed the city-specific effect estimates, bc,
to be normally distributed around an overall
estimate. To test whether variability in bc was
explained by city characteristics, we estimated
ﬁxed-effects pooled regression coefﬁcients by
weighted regression of bc on potential effect
modifiers (at the city level) with weights
inversely proportional to the variances of bc
(DerSimonian and Laird 1986). If we found
substantial heterogeneity across cities, beyond
the variation associated with the effect modi-
fiers, we applied random-effects regression
models. These models assumed that bc was a
sample of independent observations from a
normal distribution with the same mean and
with variances equal to the between-city vari-
ance and the squared SE of bc. We estimated
the random variance component by iteratively
reweighted least squares (Berkey et al. 1995).
Based on exploratory analysis, we exam-
ined potential effect modification patterns
only for cities with complete time-series data
and for the effects of the average of 2-day air
pollution (lags 0 and 1) because these were
more heterogeneous and there were indica-
tions that they were relatively insensitive to
the choice of analytic method. Because there
were differences in the distribution of the
effect modiﬁers between Europe and United
States, the cut points for establishing cate-
gories for these variables were center speciﬁc.
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Table 1. Percent increase (95% CI) in the daily number of deaths (all ages and ≥ 75 and < 75 years of age)
associated with an increase of 10 μg/m3 in PM10 concentrations (estimated by using 8 df/year to control
for seasonal patterns and PS) in the three centers.
Total mortality
Controlling Distributed lag 
Age group/center Lag 1 for O3 (lag 1) Average of lags 0, 1 models (lags 0, 1, 2)
All ages (years)
Canada 0.84 (0.30 to 1.40) 0.76 (0.20 to 1.30) NA NA
Europe 0.33 (0.22 to 0.44) 0.32 (0.21 to 0.42) 0.29 (0.14 to 0.45) 0.20 (–0.01 to 0.42)
United Statesa 0.29 (0.18 to 0.40) 0.24 (0.08 to 0.41) 0.14 (–0.12 to 0.40) 0.26 (–0.08 to 0.61)
≥ 75 years
Canada 1.00 (0.25 to 1.80) 0.98 (0.18 to 1.80) NA NA
Europe 0.44 (0.29 to 0.58) 0.41 (0.27 to 0.54) 0.39 (0.19 to 0.59) 0.32 (0.04 to 0.60)
United Statesa 0.47 (0.31 to 0.63) 0.37 (0.16 to 0.59) 0.19 (–0.19 to 0.56) 0.33 (–0.16 to 0.82)
< 75 years
Canada 0.63 (–0.12 to 1.40) 0.51 (–0.26 to 1.30) NA NA
Europe 0.25 (0.10 to 0.40) 0.23 (0.07 to 0.39) 0.25 (0.09 to 0.42) 0.11 (–0.20 to 0.43)
United Statesa 0.12 (–0.02 to 0.27) 0.10 (–0.13 to 0.34) 0.09 (–0.20 to 0.38) 0.20 (–0.24 to 0.63)
Abbreviations: CI, conﬁdence interval; NA, not applied because of systematically missing data. 
aWe based the U.S. estimates for lag 1 on 90 cities, and the average of lags 0 and 1 and distributed lag models on 15 cities.
Figure 1. Percent increase in the daily number of deaths, for all ages, associated with a 10-μg/m3 increase in
PM10: lag 1 (A) and lags 0 and 1 (B) for all three centers. PACF indicates df based on minimization of PACF.
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Table 1 summarizes the center-speciﬁc percent
increases in the daily number of deaths (all ages
and by age group) associated with an increase
of 10 µg/m3 in PM10 concentrations, with and
without control for O3, estimated by models
using 8 df/year and PS, by various lags. (Table
1 presents results from the model using 8 df
per year for seasonality control, thus reporting
relatively conservative estimates among those
from the different modeling strategies applied.)
For the Canadian cities, which have measure-
ments for 1 of 6 days, only lag 1 PM10 expo-
sure could be considered. Similarly, most U.S.
cities had data for 1 of 6 days, so we based the
U.S. estimates for lag 1 and longer lags on dif-
ferent numbers of cities (90 and 15, respec-
tively). Air pollution risk estimates for the
Canadian cities were about 2-fold higher than
those for Europe and the United States. We
estimated a lag 1 increase of 10 µg/m3 PM10 to
increase the daily number of deaths by 0.84%
[95% conﬁdence interval (CI), 0.30–1.40%]
for Canadian cities, 0.33% (95% CI,
0.22–0.44%) for European cities, and 0.29%
(95% CI, 0.18–0.40%) for U.S. cities. These
estimates decreased slightly with adjustment
for O3. The effect estimates for people ≥ 75
years of age were consistently larger than those
for people < 75 years of age. The previous day’s
effects for all ages and for the elderly were
statistically signiﬁcant in all three centers.
When considering the average effect for
lags 0 and 1, we estimated an increase of
0.29% (95% CI, 0.14–0.45%) in the daily
number of deaths per 10 µg/m3 in PM10 for
European cities and 0.14% (95% CI, –0.12%
to 0.40%) for U.S. cities with daily PM10
measurements. The effects were higher for the
older age group compared with those
< 75 years of age. The effects of cumulative
exposure, assessed with distributed lag models
of lags 0–2, were somewhat lower for
European cities than for U.S. cities. PM10
effect estimates did not change when con-
trolled for O3 levels. When we analyzed the
effect of the previous day’s PM10 in the 15
U.S. cities with daily time-series data, the cor-
responding estimates were comparable with
those obtained for all 90 U.S. cities, indicat-
ing that these 15 cities do not differ systemat-
ically from the larger group of 90 cities.
Figure 1 shows the sensitivity of ﬁndings to
the analytic approach. Figure 1A gives mortal-
ity risk estimates for lag 1 PM10 concentrations
by center. We did not pool the substantially
higher estimates for the Canadian cities with
those for the U.S. and European cities. There
is a tendency for lower estimates to be obtained
with greater values of df. Figure 1B shows the
results for lags 0 and 1 for cities with daily data
(Canadian cities had missing data). The pat-
tern of variation in risk estimates with df was
similar to that seen with the lag 1 data. The
combined increases in the total number of
deaths estimated were 0.25% with PS and
0.18% with NS at 8 df/year, 0.21% with PS
and 0.18% with NS at 12 df/year, and 0.42%
with PS and 0.25% with NS using the PACF
criterion. On average, the PACF method
resulted in the selection of 5–6 df per year for
seasonality control.
Figure 2 shows the effects of PM air
pollution on total mortality among persons
≥ 75 years of age. Air pollution risk estimates
were higher than those for all ages combined.
Because of the difference in effect size for
Canada compared with Europe and the
United States, we do not provide combined
estimates for lag 1. Figure 3 gives the corre-
sponding estimates for those < 75 years of
age. Although the size of the PM10 effect is
smaller, the combined effect for lag 0 and 1 is
statistically signiﬁcant.
The estimated effects of PM10 on cardio-
vascular mortality (data not shown) were gen-
erally similar to those for total mortality.
Among those ≥ 75 years of age, the effects on
cardiovascular mortality were larger than those
on total mortality. Speciﬁcally, we estimated
lag 1 PM10 to increase the daily number of
cardiovascular deaths among the elderly by
1.30% (95% CI, 0.19–2.40%) in the Canadian
cities, 0.47% (95% CI, 0.23–0.70%) in the
European cities, and 0.51% (95% CI,
0.29–0.73%) in the U.S. cities. The corre-
sponding estimates for cardiovascular mortality
among people < 75 years of age were positive
but not signiﬁcant. There were far fewer respi-
ratory deaths than cardiovascular deaths in all
three centers. The results for respiratory mortal-
ity were less consistent. PM10 at lag 0 and 1 was
more consistently associated with increased res-
piratory mortality, again with larger effects
among those ≥ 75 years of age.
We investigated effect modification pat-
terns only for cities with a complete PM10 time
series. For most of the analytic scenarios consid-
ered, the time-series models produced statisti-
cally significant effects of PM10 on total
mortality. However, there was signiﬁcant het-
erogeneity in the city-speciﬁc estimates of the
effects of PM10 on total mortality across all ages
and among those ≥ 75 years of age. Increasing
the df to control for seasonality decreased the
magnitude of the air pollution effect and, con-
sequently, the degree of observed heterogeneity.
The ﬁrst-stage results for the European cities
were more heterogeneous than those for the
U.S. cities. Nevertheless, the European pooled
results were more consistent across analytic
methods. A detailed presentation of the
APHENA second-stage analysis results is avail-
able in the Supplemental Material (online at
http://www.ehponline.org/members/2008/
11345/suppl.pdf).
Effects of particulate matter on mortality
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Figure 2. Percent increase in the daily number of deaths, among those ≥ 75 years of age, associated with a
10-μg/m3 increase in PM10: lag 1 (A) and lags 0 and 1 (B) for all three centers. PACF indicates df based on
minimization of PACF.
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Figure 3. Percent increase in the daily number of deaths, among those < 75 years of age, associated with a
10-μg/m3 increase in PM10: lag 1 (A) and lags 0 and 1 (B) for all three centers. PACF indicates df based on
minimization of PACF.
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consistent across analytic methods, particularly
for those variables having a signiﬁcant modify-
ing effect on the association between PM air
pollution and mortality. The effect modiﬁca-
tion patterns identified in Europe and the
United States were not always consistent.
With respect to characteristics of exposure, we
found that in Europe higher levels of NO2
and a larger NO2:PM10 ratio were associated
with a greater PM10 effect on mortality. This
pattern was also present in the United States
but was less pronounced. In contrast, we saw a
smaller PM10 effect on mortality among the
elderly in cities with higher O3 levels, a pat-
tern mainly observed in the U.S. cities. Effect
modification by climate was evident in
Europe, where higher temperature and lower
humidity were associated with larger PM10
effects. We found no consistent pattern of
effect modification with temperature in the
United States, and the association with
humidity tended to be inverse. When we
investigated variables characterizing the age
structure and health status of the population,
an increasing proportion of elderly people was
associated with higher PM10 effects in both
Europe and the United States. A larger pro-
portion of cardiorespiratory deaths among all
deaths was associated with higher PM10 effects
only in the United States, and there only
among the elderly. The corresponding pattern
in Europe was nonsigniﬁcant and tended to be
the inverse. A higher crude mortality rate was
associated with a higher PM10 effect in the
United States. The only socioeconomic factor
available for all cities was the percentage of
unemployed: a higher percentage of unem-
ployed was associated with greater PM air
pollution effects on both continents.
Investigation of the exposure–response
relationship between PM10 and total mortal-
ity across all ages in APHENA did not sup-
port the presence of a threshold in any of the
three centers. If a threshold were present, we
would expect to see a U-shaped curve when
we plot the AIC values for the various thresh-
old models against the thresholds used, with
the minimum AIC value corresponding to the
threshold. In fact, within each center, the
city-speciﬁc AIC plots were quite ﬂat for most
cities (data not shown).
Discussion
In this article, we report the results of a com-
prehensive analysis of time-series data relating
PM air pollution to mortality in the general
population in 124 cities in Europe (22 cities),
the United States (90 cities), and Canada
(12 cities). The analysis protocol used in the
APHENA study was informed by theoretical
developments, sensitivity analyses, and simula-
tions, which we then used to complete a com-
prehensive reanalysis of time-series data from
Europe and North America. Overall, using
this common protocol, PM10 was associated
with increased total mortality, particularly
among those ≥ 75 years of age, in all three
centers (Europe, United States, and Canada),
with the effect notably greater in Canadian
cities. Mortality risk estimates tended to
decrease with increasing adjustment for
unmeasured time-varying covariates and were
generally lower for the average of lags 0 and 1,
compared with lag 1 alone. Distributed lag
models exhibited a different risk pattern
between the United States and Europe, with a
more prolonged effect of exposure to PM10
seen in the United States.
The effects of PM10 on total mortality in
European and U.S. cities were quite similar.
Based on different modeling approaches, results
from the same data sets have been previously
reported and were quite close, with the small
discrepancies noted possibly due to the differing
modeling approaches. For the European cities,
one APHEA report (Katsouyanni et al. 2001)
provided an estimate of 0.6% increase in the
daily total number of deaths per 10 µg/m3
PM10, whereas the reanalysis provided an esti-
mate of 0.4% (HEI 2003). Similarly, original
NMMAPS results reported in Samet et al.
(2000b) estimated an increase in the number
of deaths of 0.4%, and the reanalysis reported a
0.2% increase (HEI 2003) based on 90 U.S.
cities. Within the context of APHENA, we
had the opportunity to expand the investiga-
tion of within-center heterogeneity previously
reported. The main effect modification pat-
terns identiﬁed by Katsouyanni et al. (2001)
were replicated within APHENA, and several
new modifiers were identified as well—for
example, the modifying effect of the percent-
age of unemployed on the association between
PM air pollution and mortality. The signifi-
cantly higher estimates observed in Canada
previously (0.8%; HEI 2003) persisted in the
present APHENA analysis.
Because we analyzed the data according to
standardized criteria in APHENA, the higher
values observed in Canada cannot be attributed
to differences in analytic approaches. Never-
theless, city-speciﬁc estimates of the effect of
PM10 on mortality for Canadian cities such as
Toronto (in which mortality among the
elderly was increased by 1.4% for a 10-µg/m3
increase in PM10) and U.S. cities of similar
population size and climate such as Detroit,
Michigan (0.8% mortality increase), were
close. The trend toward higher estimates could
possibly be the result of more accurate expo-
sure and outcome data in Canada compared
with the European countries and the United
States. (At this point, we have no validation
data available to explore this possibility.)
Although the effect of PM10 on mortality may
be greater in Canada compared with the other
countries, we cannot readily identify any
specific source mix differences among the
APHENA countries that might explain this
difference. Alternatively, although no thresh-
old has been detected in the exposure–
response association between ambient PM and
mortality, there may be a log-linear association
between air pollution and mortality, for which
lower pollution levels contribute larger risks;
under this hypothesis, the lower air pollution
concentrations in Canadian cities would lead
to higher risks. An additional explanation,
which cannot be explored with the APHENA
data, would be that PM10 acts primarily as a
surrogate of the true causal pollutants and that
the relationship between PM10 and the toxic
components differs in Canada compared with
the other countries.
Several meta-analyses of the effect of PM10
on mortality have been reported (Anderson
et al. 2004, 2005; Pope and Dockery 2006;
Stieb et al. 2002, 2003). The combined esti-
mates from single-city studies tend to be
higher, partly because not all estimates have
been revised subsequent to the identiﬁcation of
the S-Plus convergence criteria issue (Anderson
et al. 2005). Furthermore, aspects of city selec-
tion and model speciﬁcation in the single-city
studies may have led to upwardly biased esti-
mates; there is also some evidence of publica-
tion bias, which would also tend to result in an
upward bias (Anderson et al. 2005). Summary
estimates from single-city studies range from
about 0.4% to 0.8% per 10 µg/m3 PM10
(Pope and Dockery 2006). The European and
U.S. estimates in APHENA lie just below this
range, whereas the Canadian estimates are at
the upper end of the range.
European cities tend to have a higher
prevalence of diesel vehicles, particularly pas-
senger cars, than do cities in North America
(European Commission 2005; Green Car
Congress 2008); although not characterized,
source inventories related to power generation
and industry are also likely to vary, both
between and within continents. The compa-
rability of European and U.S. risk estimates
suggests that underlying differences in PM air
pollution sources may not have substantially
affected the overall risk.
One objective of APHENA was to
explore patterns of effect modiﬁcation across
a wide range of geographic locations with air
pollution coming from differing source mix-
tures and with populations differing in
sociodemographic characteristics.
In prior analyses of both single-city and
multicity data, a number of potential modiﬁers
of associations between air pollution and mor-
tality have been identiﬁed (O’Neill et al. 2003;
U.S. EPA 2004). Within APHEA, prior analy-
ses identiﬁed modiﬁcation of the effect of PM10
on both mortality and admissions outcomes
(Aga et al. 2003; Analitis et al. 2006; Atkinson
et al. 2001; Katsouyanni et al. 2001; Le Tertre
Samoli et al.
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Samet et al. (2000a, 2000c) explored effect
modiﬁcation extensively in the original analyses
of the 90 cities’ mortality data and identiﬁed
several potential modiﬁers. Both projects found
evidence of variation by geographic region.
Similar two-stage analyses have not been carried
out previously for the Canadian cities.
We addressed effect modification in
APHENA in the second-stage analysis using
city-level variables indicative of characteristics
of the air pollution mixture, climate, age struc-
ture and health status, and SES determinants.
PM10 effect modification patterns, explored
only for cities with daily data (21 European
and 15 U.S. cities), were not entirely consis-
tent across centers and varied somewhat
depending on the underlying model and geo-
graphic location. Pollutant levels demon-
strated different modifying effects for cities in
Europe and the United States, which may be
attributed to variation in the complex mix of
air pollutants in Europe and the United States.
Climatic variables were important only in
Europe. One explanation may be related to
the lower prevalence of air conditioning in
Europe, which would lead to a higher expo-
sure of the population to outdoor air in indoor
environments. We found the most consistent
evidence of effect modification for age, with
an increasing proportion ≥ 75 years associated
with a greater effect of PM10 in both the
United States and Europe; higher percentage
of unemployment was also associated with
greater risk in both continents.
Larger proportions of persons ≥ 75 years
of age were associated in both centers with
larger PM10 effects on mortality all ages and
in this age group. This ﬁnding may be associ-
ated with lower baseline mortality, possibly
leading to higher relative risks. Another plau-
sible explanation may be that in locations
with larger proportions of those ≥ 75 years of
age, the mean age of this group is also larger,
leading to an excess effect. The positive effect
modification pattern associated with higher
unemployment suggests that populations with
lower SES may be more susceptible to PM10,
as was noted by Krewski et al. (2000) in stud-
ies of the effects of long-term exposure to
PM2.5 on mortality.
The proportion of cardiopulmonary
deaths relative to the total number of deaths
displayed an opposing pattern in European
and U.S. cities. In Europe, each national
authority was responsible for coding the
causes of death, and that the comparability of
this practice has not been evaluated.
The principal limitations in interpreting the
APHENA ﬁndings lie with the data available to
the investigators. The data came from multiple
countries and were not collected according to a
uniform protocol. Although we edited and ana-
lyzed all data extensively and used a quality
assessment audit, differing measurement error
structures across the three sets of data remains a
possible source of heterogeneity.
Although a number of potential effect
modiﬁers have been identiﬁed, the exploration
of effect modiﬁcation in APHENA was limited
by the restricted number of variables that
extended across the full data set. Finally, the
relatively small number of cities with daily data
and the large statistical uncertainty of the city-
speciﬁc estimates may have limited the power
for detecting effect modification patterns. A
more thorough discussion on the limitations of
APHENA is available in the Supplemental
Material (online at http://www.ehponline.
org/members/2008/11345/suppl.pdf).
The APHENA study led to the develop-
ment of a standardized protocol for analyses of
daily time-series data on air pollution and
mortality. We pooled data from studies that
had been carried out in multiple cities in
Europe and North America. The findings
conﬁrm the acute, adverse effects of PM10 on
mortality. The use of the primary raw data to
conduct pooled analyses in APHENA permits
more informative analysis than can be
achieved through a simpler meta-analysis of
summary risk estimates taken from the pub-
lished literature. Despite the differences in
data availability and comparability of effect
modiﬁers in Europe and North America, it is
possible to consolidate an ongoing collection
of time-series data into a single data set so that
similar analyses can be carried out periodically
in the future. For the purpose of air pollution
control, a need exists for periodic syntheses of
the literature to serve as the basis for establish-
ing air quality guidelines at the national and
international level (Craig et al. 2008); thus,
there is a strong rationale for the ongoing col-
lection and synthesis of estimates of the health
risks of air pollution. This rationale is particu-
larly compelling for regions of the world
where levels of air pollution are higher and
population susceptibility may be increased, as
well (e.g., Asia and Latin America). APHENA
has already served as an example and a source
of methodological guidance for two ongoing
coordinated multicity studies: PAPA (Public
Health and Air Pollution in Asia) and
ESCALA (Estudio de Salud y Contaminación
del Aire en Latinoamérica) (Gouveia et al.
2008; Wong 2008).
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